mobile menu icon

Bristows advises Abingdon Health on £1.5m funding round



Abingdon is a UK-based diagnostics group specialising in ‘point of care’ tests, to diagnose disease in humans, animals and plants, and to measure drugs, hormones and other biomarkers in a range of sample types. Founded in 2008 the company employs around 40 people and also has operations in Birmingham and York.

On 18 January 2019 Abingdon closed a funding round with NPIF – Mercia Equity Finance (managed by Mercia Fund Managers and part of the Northern Powerhouse Investment Fund) raising total gross proceeds of approximately £1.5m.

Members of the Bristows corporate team that advised on this transaction included:

Senior Associate Julia Cockcroft also provided tax advice to Abingdon.

The announcement of the funding has been reported online:  

For more information about the legal aspects of funding please contact our corporate team.

Sign up for newsletters

If you would like to subscribe to regular Bristows publications, please click on the Sign up button below to complete our short registration form.

Share to: